Evidence map›Paper›PMID 20308066›Full record

ArticleThe Journal of biological chemistry2010

LVIS553 transcriptional regulator specifically recognizes novobiocin as an effector molecule.

Fernando A Pagliai, Christopher L Gardner, Santosh G Pande, Graciela L Lorca

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. The Sdp-SH3b2 domain contained inFrontiers in immunology · 2024
    Article
  3. A serralysin-like protein ofFrontiers in microbiology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fernando A PagliaiDepartment of Microbiology and Cell Science, Genetics Institute, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida 32610-3610, USA.
Christopher L Gardner
Santosh G Pande
Graciela L Lorca
University of Florida · US

Funding

Identification of New Lactobacillus Regulators Responsive to FDA-Approved DrugsR03AI078001 · NIAID · UNIVERSITY OF FLORIDA · PI LORCA, GRACIELA L · 2009 to 2010
$146k
NIAID NIH HHS R03 AI078001
6 · The paper itself

Abstract

In this study we aimed to identify small molecules with high affinity involved in the allosteric regulation of LVIS553, a MarR member from Lactobacillus brevis ATCC367. Using high throughput screening, novobiocin was found to specifically bind LVIS553 with a K(D) = 33.8 +/- 2.9 microM consistent with a biologically relevant ligand. Structure guided site-directed mutagenesis identified Lys(9) as a key residue in novobiocin recognition. The results found in vitro were correlated in vivo. An increased tolerance to the antibiotic was observed when LVIS553 and the downstream putative transport protein LVIS552 were either expressed in a low copy plasmid in L. brevis or as a single copy chromosomal insertion in Bacillus subtilis. We provide evidence that LVIS553 is involved in the specific regulation of a new mechanism of tolerance to novobiocin.

Indexed as

Transcription, GeneticAllosteric SiteAnti-Bacterial AgentsBacillus subtilisChromosomesDeoxyribonuclease IDose-Response Relationship, DrugEscherichia coli ProteinsFluorometryKineticsLevilactobacillus brevisLigandsLysineMutagenesis, Site-DirectedNovobiocinRepressor ProteinsAnti-Bacterial AgentsDeoxyribonuclease IEscherichia coli ProteinsLigandsLysineMarR protein, E coliNovobiocinRepressor ProteinsTranscription Factors

Identifiers

PMID20308066
PMCPMC2878039
OpenAlexW2021163216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.